NCT02915523 2024-01-10
Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer
Syndax Pharmaceuticals
Phase 1/2 Completed
Syndax Pharmaceuticals
Institut Bergonié
NanOlogy, LLC
NuCana plc
Boston Scientific Corporation